Home | Welcome to Contract Pharma   
Last Updated Thursday, August 21 2014
Print

Breaking News

Related Searches:
February 3, 2011
Genard in as quality director at steriles site  Read More »
February 3, 2011
Vorapaxar cancellation causes $1.7 billion hit  Read More »
February 2, 2011
Asia-Pacific sales growth outstrips other regions.  Read More »
February 2, 2011
Without Tamiflu revenues, pharma dipped.  Read More »
February 2, 2011
Modern insulins drive growth for NN  Read More »
February 2, 2011
Acquisitions help with revenue growth  Read More »
February 2, 2011
ICH compliance enhances stability offerings  Read More »
February 1, 2011
Greenstreet to head medicines development for Specialty Care  Read More »
February 1, 2011
Wyeth products boost revenues, but a decline is predicted  Read More »
February 1, 2011
Tysabri, Avonex revenues continue to climb  Read More »
February 1, 2011
Henderson named VP, general counsel and secretary  Read More »
February 1, 2011
New name focuses on biopharma services  Read More »
January 31, 2011
Brussels site to formulate, fill, package interferon product for Phase III, potential commercial supply  Read More »
January 31, 2011
Expands preclinical pipeline and translational base with $111 million acquisition.  Read More »
January 31, 2011
Pfizer, OncoMed advance HuCAL programs  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On